MicroRNA-1 induces apoptosis by targeting prothymosin alpha in nasopharyngeal carcinoma cells

Journal of Biomedical Science

Volumn 18, Issue 1, 2011, Pages

  Wu, Cheng Der ^a   Kuo, Yuan Sung ^b   Wu, Han Chung ^c   Lin, Chin Tarng ^a,b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c INSTITUTE OF CELLULAR AND ORGANISMIC BIOLOGY   (Taiwan)

Author keywords

apoptosis; microRNA 1 (miR 1); nasopharyngeal carcinoma (NPC); ProTalpha); PTMA (prothymosin alpha

Indexed keywords

CAMPTOTHECIN; CASPASE; COMPLEMENTARY DNA; DACTINOMYCIN; ETOPOSIDE; LIPOCORTIN 5; LUCIFERASE; MICRORNA; MICRORNA 1; PROTHYMOSIN ALPHA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; DRUG DERIVATIVE; MIRN1 MICRORNA, HUMAN; PROTEIN PRECURSOR; THYMOSIN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL STRAIN HEK293; CELL STRAIN HEPG2; CONTROLLED STUDY; ENZYME ASSAY; GENE EXPRESSION; GENE TARGETING; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; NASOPHARYNX CARCINOMA; NICK END LABELING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; GENETICS; METABOLISM; NASOPHARYNX TUMOR; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS; CELL LINE, TUMOR; HUMANS; MICRORNAS; NASOPHARYNGEAL NEOPLASMS; PROTEIN PRECURSORS; THYMOSIN; TRANSFECTION;

EID: 80355132691     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1186/1423-0127-18-80     Document Type: Article

References (24)

1. The microRNA pathway and cancer. Kwak PB, Iwasaki S, Tomari Y, Cancer Sci 2010 101 2309 2315 10.1111/j.1349-7006.2010.01683.x 20726859
2. microRNA and cancer. Li M, Li J, Ding X, He M, Cheng SY, AAPS J 2010 12 309 317 10.1208/s12248-010-9194-0 20422339
3. Apoptosis, oncosis, and necrosis. An overview of cell death. Majno G, Joris I, Am J Pathol 1995 146 3 15 7856735
4. Morphological and biochemical aspects of apoptosis, oncosis and necrosis. Van Cruchten S, Van Den Broeck W, Anat Histol Embryol 2002 31 214 223 10.1046/j.1439-0264.2002.00398.x 12196263
5. Prothymosin alpha: isolation and properties of the major immunoreactive form of thymosin alpha 1 in rat thymus. Haritos AA, Goodall GJ, Horecker BL, Proc Natl Acad Sci USA 1984 81 1008 1011 10.1073/pnas.81.4.1008 6583693 (Pubitemid 14125638)
6. The expression of prothymosin alpha gene in T lymphocytes and leukemic lymphoid cells is tied to lymphocyte proliferation. Gomez-Marquez J, Segade F, Dosil M, Pichel JG, Bustelo XR, Freire M, J Biol Chem 1989 264 8451 8454 2785990 (Pubitemid 19151549)
7. Expression of alpha-thymosins in human tissues in normal and abnormal growth. Tsitsiloni OE, Stiakakis J, Koutselinis A, Gogas J, Markopoulos C, Yialouris P, Bekris S, Panoussopoulos D, Kiortsis V, Voelter W, et al. Proc Natl Acad Sci USA 1993 90 9504 9507 10.1073/pnas.90.20.9504 8415730 (Pubitemid 23315813)
8. Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway. Jiang X, Kim HE, Shu H, Zhao Y, Zhang H, Kofron J, Donnelly J, Burns D, Ng SC, Rosenberg S, Wang X, Science 2003 299 223 226 10.1126/science.1076807 12522243 (Pubitemid 36125203)
9. Novel small molecules relieve prothymosin alpha-mediated inhibition of apoptosome formation by blocking its interaction with Apaf-1. Qi X, Wang L, Du F, Biochemistry 2010 49 1923 1930 10.1021/bi9022329 20121050
10. Cytogenetic characterization of a nasopharyngeal carcinoma cell line and its subline. Tien HF, Lee FY, Chuang SM, Lin CT, Cancer Genet Cytogenet 1990 49 31 36 10.1016/0165-4608(90)90161-3 2397471 (Pubitemid 20340775)
11. Establishment and characterization of two nasopharyngeal carcinoma cell lines. Lin CT, Wong CI, Chan WY, Tzung KW, Ho JK, Hsu MM, Chuang SM, Lab Invest 1990 62 713 724 2162997 (Pubitemid 20213689)
12. Characterization of seven newly established nasopharyngeal carcinoma cell lines. Lin CT, Chan WY, Chen W, Huang HM, Wu HC, Hsu MM, Chuang SM, Wang CC, Lab Invest 1993 68 716 727 7685844
13. Upregulated expression of miR-1/miR-206 in a rat model of myocardial infarction. Shan ZX, Lin QX, Fu YH, Deng CY, Zhou ZL, Zhu JN, Liu XY, Zhang YY, Li Y, Lin SG, Yu XY, Biochem Biophys Res Commun 2009 381 597 601 10.1016/j.bbrc.2009.02.097 19245789
14. The muscle-specific microRNAs miR-1 and miR-133 produce opposing effects on apoptosis by targeting HSP60, HSP70 and caspase-9 in cardiomyocytes. Xu C, Lu Y, Pan Z, Chu W, Luo X, Lin H, Xiao J, Shan H, Wang Z, Yang B, J Cell Sci 2007 120 3045 3052 10.1242/jcs.010728 17715156 (Pubitemid 47517087)
15. MicroRNA-1 regulates cardiomyocyte apoptosis by targeting Bcl-2. Tang Y, Zheng J, Sun Y, Wu Z, Liu Z, Huang G, Int Heart J 2009 50 377 387 10.1536/ihj.50.377 19506341
16. Glucose induces apoptosis of cardiomyocytes via microRNA-1 and IGF-1. Yu XY, Song YH, Geng YJ, Lin QX, Shan ZX, Lin SG, Li Y, Biochem Biophys Res Commun 2008 376 548 552 10.1016/j.bbrc.2008.09.025 18801338
17. miR-1/miR-206 regulate Hsp60 expression contributing to glucose-mediated apoptosis in cardiomyocytes. Shan ZX, Lin QX, Deng CY, Zhu JN, Mai LP, Liu JL, Fu YH, Liu XY, Li YX, Zhang YY, et al. FEBS Lett 2010 584 3592 3600 10.1016/j.febslet.2010.07.027 20655308
18. Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis. Datta J, Kutay H, Nasser MW, Nuovo GJ, Wang B, Majumder S, Liu CG, Volinia S, Croce CM, Schmittgen TD, et al. Cancer Res 2008 68 5049 5058 10.1158/0008-5472.CAN-07-6655 18593903
19. MyoD regulates apoptosis of myoblasts through microRNA-mediated down-regulation of Pax3. Hirai H, Verma M, Watanabe S, Tastad C, Asakura Y, Asakura A, J Cell Biol 2010 191 347 365 10.1083/jcb.201006025 20956382
20. Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1. Nasser MW, Datta J, Nuovo G, Kutay H, Motiwala T, Majumder S, Wang B, Suster S, Jacob ST, Ghoshal K, J Biol Chem 2008 283 33394 33405 10.1074/jbc.M804788200 18818206
21. The tumour-suppressive function of miR-1 and miR-133a targeting TAGLN2 in bladder cancer. Yoshino H, Chiyomaru T, Enokida H, Kawakami K, Tatarano S, Nishiyama K, Nohata N, Seki N, Nakagawa M, Br J Cancer 2011 104 808 818 10.1038/bjc.2011.23 21304530
22. miR-1 as a tumor suppressive microRNA targeting TAGLN2 in head and neck squamous cell carcinoma. Nohata N, Sone Y, Hanazawa T, Fuse M, Kikkawa N, Yoshino H, Chiyomaru T, Kawakami K, Enokida H, Nakagawa M, et al. Oncotarget 2011 2 29 42 21378409
23. Prothymosin-alpha plays a defensive role in retinal ischemia through necrosis and apoptosis inhibition. Fujita R, Ueda M, Fujiwara K, Ueda H, Cell Death Differ 2009 16 349 358 10.1038/cdd.2008.159 18989338
24. Surfing on prothymosin alpha proliferation and anti-apoptotic properties. Letsas KP, Frangou-Lazaridis M, Neoplasma 2006 53 92 96 16575463